Press Releases - 2023-09-26

Date	Title	Company
26-Sep-2023	Alpha-1 Antitrypsin Deficiency Market Booms to US$10 Billion by 2033, Propelled by a Noteworthy 12.8% CAGR \| FMI Report	MARKITWIRED
26-Sep-2023	FMI Reveals Remarkable Forecast for the Chronic Obstructive Pulmonary Disease (COPD): Expected to Reach US$33.19 Billion with a 4.4% CAGR by 2033	MARKITWIRED
26-Sep-2023	AlzeCure gets presentation accepted on disease-modifying effects of ACD856 at Alzheimer’s conference	AlzeCure
26-Sep-2023	Oncopeptides announces successful price negotiations for Pepaxti in Germany	Oncopeptides AB
26-Sep-2023	UCB announces approval of RYSTIGGO® (rozanolixizumab) and ZILBRYSQ® (zilucoplan) for the treatment of adult patients with generalized myasthenia gravis in Japan	UCB
26-Sep-2023	XBiotech Announces Enrollment Completion of Phase I Clinical Trial for Hutrukin, a Novel Candidate Therapy for Stroke	XBiotech Inc.
26-Sep-2023	Northern Gritstone and Argobio Studio back Sheffield University spin-out Crucible Therapeutics	Crucible Therapeutics
26-Sep-2023	FMI Report Predicts Remarkable 7.9% CAGR, Forecasting US$5.91 Billion Valuation for Dental Imaging Equipment Market by 2030	MARKITWIRED
26-Sep-2023	Breast Imaging Market’s Exceptional 7.1% CAGR Transformation, Predicting US$8.5 Billion by 2032 \| FMI Analysis Revealed	MARKITWIRED
26-Sep-2023	Dupixent® (dupilumab) sBLA for Treatment of Eosinophilic Esophagitis (EoE) in Children Aged 1 to 11 Accepted for FDA Priority Review	Regeneron Pharmaceuticals
26-Sep-2023	In vitro lung cell exposure systems by VITROCELL at EUROTOX 2023	VITROCELL
26-Sep-2023	Aidoc's AI Solution for Pulmonary Embolism Clinically Proven to Reduce Hospital Stay Duration and Improves Patient Access to Treatment	Aidoc
26-Sep-2023	Acesion Pharma Closes Oversubscribed €45M Series B Financing Round to Advance Development of Novel Therapy for Atrial Fibrillation	Acesion Pharma
26-Sep-2023	Polpharma Biologics Announces Approval of Europe’s First and Only Biosimilar for Multiple Sclerosis - Tyruko® (Natalizumab)	Polpharma Biologics
26-Sep-2023	Senseonics Announces the Last Patient Completion of the 365-Day ENHANCE Pivotal Clinical Study	Senseonics
26-Sep-2023	FMI’s Revealing Insights: Anemia Treatment Market on Track to Reach US$14.9 Billion by 2028, at an impressive CAGR of 6.9%.	MARKITWIRED
26-Sep-2023	Biosynth extends its offering to multi-kilogram GMP peptide synthesis through the acquisition of Pepceuticals	Biosynth
26-Sep-2023	Hypercalcemia Treatment Market’s Ascent: Reaching US$18.07 Billion by 2023, Aiming for US$55.07 Billion by 2033 \| Reveals by FMI	MARKITWIRED
26-Sep-2023	Lundbeckfonden BioCapital and +ND Capital join forces: New investment in novel hormone-free fertility treatment for women	Lundbeckfonden BioCapital
26-Sep-2023	4SC: Landmark RESMAIN study data presented at the EORTC Cutaneous Lymphoma Tumour Group Annual Meeting	4SC AG